.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
QuintilesIMS
Johnson and Johnson
Deloitte
Express Scripts
Teva
Cerilliant
US Army
Daiichi Sankyo
UBS

Generated: September 26, 2017

DrugPatentWatch Database Preview

Drug Master Files for: pseudoephedrine

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
1002I10/13/1966NYSCO LABS INCPSEUDOEPHEDRINE HCL TIMED RELEASE PELLETS
2154III9/10/1973KV PHARMACEUTICAL COPSEUDOEPHEDRINE HCL 120MG S.R. CAPS.
2231III8/17/1973KV PHARMACEUTICAL COPSEUDOEPHEDRINE HCL & CHLORPHENIRAMINE MALEATE S.R.C.
2513III8/13/1975KV PHARMACEUTICAL COPSEUDOEPHEDRINE HCL SRC
2516AII8/28/1975NOVUS FINE CHEMICALS LLCPSEUDOEPHEDRINE HCL, SULFATE, AND BASE BULK POWDER
2964III6/7/1977KV PHARMACEUTICAL COACTIFED S.A. CAPS--PSEUDOEPHEDRINE HCL 120MG/TRIPROLIDINE
3620III9/6/1979DM GRAHAM LABORATORIES INCD-PSEUDOEPHEDRINE FOR TIME RELEASE BEAD
4132III4/20/1981H REISMAN CORPPSEUDOEPHEDRINE HCL; BULK PSEUDOEPHEDRINE HCL
4161III4/29/1981CENTRAL PHARMACEUTICALS INCPSEUDOEPHEDRINE HCL CAPS 120MG
4185AII5/27/1981SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHPSEUDOEPHEDRINE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Chubb
Moodys
Medtronic
Merck
UBS
US Department of Justice
Cerilliant
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot